Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 23, 2006

Hypertension. 2006
Published online before print January 23, 2006, doi: 10.1161/01.HYP.0000202480.06735.82
A more recent version of this article appeared on March 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/3/434    most recent
01.HYP.0000202480.06735.82v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laffer, C. L.
Right arrow Articles by Elijovich, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffer, C. L.
Right arrow Articles by Elijovich, F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*FUROSEMIDE
*PROSTAGLANDIN F2ALPHA
*SODIUM CHLORIDE
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical Studies
Right arrow Other Vascular biology

Submitted on November 3, 2005
Revised on November 30, 2005

Effect of Salt on Isoprostanes in Salt-Sensitive Essential Hypertension

Cheryl L. Laffer*; Rodney J. Bolterman; Juan Carlos Romero; and Fernando Elijovich

From the Department of Pharmacology (C.L.L., F.E.), New York Medical College, Valhalla, NY; and Department of Physiology and Biophysics (R.J.B., J.C.R.), Mayo School of Medicine, Rochester, Minn.

* To whom correspondence should be addressed. E-mail: claffer{at}alumni.caltech.edu.

Abstract--The controversy over beneficial versus harmful effects of salt on cardiovascular outcomes may be caused by different effects of salt on intermediate phenotypes of hypertension not characterized in epidemiological studies. Hence, we investigated acute effects of salt on oxidative stress in hypertensive subjects classified as salt sensitive (SS, n=14) or salt resistant (SR, n=13) by an inpatient protocol of salt loading (460 mmol NaCl) and salt depletion (10 mmol NaCl and furosemide). Oxidative stress was assessed by measuring the plasma isoprostane 8-iso-PGF2{alpha}. SS had lower plasma renin activity, higher aldosterone/renin ratios, and exaggerated endothelin and catecholamine responses to salt depletion compared with SR. Baseline lipid-bound isoprostanes (749±70 pmol/L) were 83% of the total and were slightly but not significantly higher in SS than SR. Baseline free isoprostanes did not differ between groups. After salt loading, lipid-bound isoprostanes were higher in SS (945±106) than SR (579±57; P<0.01). Salt depletion significantly decreased them in SS (-174±84) and increased them in SR (+129±58), equalizing their levels (771±61 versus 708±91; P value not significant). Free isoprostanes were decreased by salt depletion only if data in all of the patients were analyzed together. Total isoprostanes followed the pattern of the lipid-bound fraction. Correlations between salt depletion-induced changes in lipid-bound isoprostanes, plasma renin activity (r=0.45; P<0.02), and aldosterone/renin ratios (r=-0.41; P<0.04) suggested that the more SS the patient, the greater the reduction of oxidative stress by salt depletion. Our research is the first to show that salt affects oxidative stress acutely in humans, particularly in SS hypertension, which may explain the controversial results of epidemiological studies on salt and morbidity and may have implications for therapy.


Key words: hypertension, essential • hypertension, sodium dependent • oxidative stress • prostaglandins • sodium • human




This article has been cited by other articles:


Home page
Circ. Res.Home page
R. A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, M. Didie, A. Steenpass, S. Ergun, and R. H. Boger
Isoprostanes Inhibit Vascular Endothelial Growth Factor-Induced Endothelial Cell Migration, Tube Formation, and Cardiac Vessel Sprouting In Vitro, As Well As Angiogenesis In Vivo via Activation of the Thromboxane A2 Receptor: A Potential Link Between Oxidative Stress and Impaired Angiogenesis
Circ. Res., October 24, 2008; 103(9): 1037 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Mimran and G. du Cailar
Dietary sodium: the dark horse amongst cardiovascular and renal risk factors
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2138 - 2141.
[Full Text] [PDF]


Home page
HypertensionHome page
M. Fujita, K. Ando, A. Nagae, and T. Fujita
Sympathoexcitation by Oxidative Stress in the Brain Mediates Arterial Pressure Elevation in Salt-Sensitive Hypertension
Hypertension, August 1, 2007; 50(2): 360 - 367.
[Abstract] [Full Text] [PDF]